Edition:
United States

Aurinia Pharmaceuticals Inc (AUPH.OQ)

AUPH.OQ on NASDAQ Stock Exchange Global Market

5.81USD
20 Jul 2018
Change (% chg)

$0.09 (+1.57%)
Prev Close
$5.72
Open
$5.76
Day's High
$5.82
Day's Low
$5.70
Volume
31,419
Avg. Vol
92,208
52-wk High
$7.60
52-wk Low
$4.41

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 4 0.05 0.10 0.03 0.03
Quarter Ending Dec-18 4 0.05 0.10 0.03 0.03
Year Ending Dec-18 5 0.16 0.30 0.12 0.14
Year Ending Dec-19 6 0.13 0.20 0.11 0.13
Earnings (per share)
Quarter Ending Sep-18 4 -0.18 -0.16 -0.19 -0.19
Quarter Ending Dec-18 4 -0.19 -0.17 -0.20 -0.20
Year Ending Dec-18 5 -0.68 -0.59 -0.74 -0.55
Year Ending Dec-19 6 -0.73 -0.42 -0.95 -0.35
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 217.69 33.34
P/E High - Last 5 Yrs. -- 284.50 47.12
P/E Low - Last 5 Yrs. -- 96.76 24.95
Beta -- 0.76 0.81
Price to Sales (TTM) -- 256.17 8.11
Price to Book (MRQ) -- 21.19 4.23
Price to Tangible Book (MRQ) -- 27.03 6.21
Price to Cash Flow (TTM) -- 128.89 22.22
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.72
Dividend Yield - 5 Year Avg -- 0.21 1.46
Dividend 5 Year Growth Rate -- 2.25 -6.39
Payout Ratio(TTM) -- 84.35 47.39

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 33.43 4.76
Sales (TTM) vs TTM 1 Yr. Ago -- 147.14 12.32
Sales - 5 Yr. Growth Rate -- 30.77 7.68
EPS (MRQ) vs Qtr. 1 Yr. Ago -- -79.61 48.99
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 46.75 7.97
Capital Spending - 5 Yr. Growth Rate -- 42.60 7.61

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.72 2.56
Current Ratio (MRQ) -- 6.63 3.63
LT Debt to Equity (MRQ) -- 24.46 13.08
Total Debt to Equity (MRQ) -- 28.66 17.18
Interest Coverage (TTM) -- -154.53 35.06

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.90 55.23
Gross Margin - 5 Yr. Avg. -- 53.43 53.18
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -182.15 15.61
Operating Margin (TTM) -- -964.42 -0.70
Operating Margin - 5 Yr. Avg. -- -195.77 10.75
Pre-Tax Margin (TTM) -- -858.38 1.18
Pre-Tax Margin - 5 Yr. Avg. -- -200.51 10.87
Net Profit Margin (TTM) -- -849.10 -2.12
Net Profit Margin - 5 Yr. Avg. -- -198.30 7.23
Effective Tax Rate (TTM) -- 14.86 20.83
Effective Tax Rate - 5 Yr. Avg. -- 19.04 24.29

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,539,371 740,084,415
Net Income/Employee (TTM) -- -1,115,845 86,307,671
Receivable Turnover (TTM) -- 17.88 5.95
Inventory Turnover (TTM) -- 2.85 3.69
Asset Turnover (TTM) -- 0.48 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -2.23 10.36
Return on Assets - 5 Yr. Avg. -- 2.95 11.03
Return on Investment (TTM) -- -3.65 13.18
Return on Investment - 5 Yr. Avg. -- 2.79 14.26
Return on Equity (TTM) -- -5.62 15.09
Return on Equity - 5 Yr. Avg. -- -4.53 15.57

Performance for Aurinia Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.